OBJECTIVE: To analyze the impact of a capitated multi-sector-financing model for psychiatric care (RPB) on costs and effectiveness of care. METHODS: Patients with a diagnosis according to ICD-10 F10, F2 or F3 were interviewed in the model region (MR, n = 258) and a control region (CR, n = 244) financed according to the fee-for-service principle. At baseline, 1.5 years and 3.5 years follow-up patients were interviewed using measures of psychopathology (CGI-S, HoNOS, SCL-90R, PANSS, BRMAS / BRMES), functioning (GAF, SOFAS) and quality of life (WHOQOL-BREF, EQ-5D). Use of care was determined semi-annually. RESULTS: There were no significant differences in the development of psychopathology and quality of life between MR and CR. In the MR, functioning of patients with schizophrenia and affective disorders improved significantly more strongly. The development of total mental health care costs was not different between MR and CR. However, the costs of office based mental health care increased slightly more strongly in the MR, indicating a small cost-shift from the RPB to extrabudgetary financed services. CONCLUSIONS: The RPB showed slight advantages regarding the effectiveness of care and did not significantly change the total mental health care costs. Georg Thieme Verlag KG Stuttgart, New York.
OBJECTIVE: To analyze the impact of a capitated multi-sector-financing model for psychiatric care (RPB) on costs and effectiveness of care. METHODS:Patients with a diagnosis according to ICD-10 F10, F2 or F3 were interviewed in the model region (MR, n = 258) and a control region (CR, n = 244) financed according to the fee-for-service principle. At baseline, 1.5 years and 3.5 years follow-up patients were interviewed using measures of psychopathology (CGI-S, HoNOS, SCL-90R, PANSS, BRMAS / BRMES), functioning (GAF, SOFAS) and quality of life (WHOQOL-BREF, EQ-5D). Use of care was determined semi-annually. RESULTS: There were no significant differences in the development of psychopathology and quality of life between MR and CR. In the MR, functioning of patients with schizophrenia and affective disorders improved significantly more strongly. The development of total mental health care costs was not different between MR and CR. However, the costs of office based mental health care increased slightly more strongly in the MR, indicating a small cost-shift from the RPB to extrabudgetary financed services. CONCLUSIONS: The RPB showed slight advantages regarding the effectiveness of care and did not significantly change the total mental health care costs. Georg Thieme Verlag KG Stuttgart, New York.
Authors: Sonja Indefrey; Bernard Braun; Sebastian von Peter; Andreas Bechdolf; Thomas Birker; Annette Duve; Olaf Hardt; Philip Heiser; Kerit Hojes; Burkhard Rehr; Harald Scherk; Anna Christina Schulz-Du Bois; Bettina Wilms; Martin Heinze Journal: Front Psychiatry Date: 2020-07-31 Impact factor: 4.157
Authors: Yuriy Ignatyev; Jürgen Timm; Martin Heinze; Sonja Indefrey; Sebastian von Peter Journal: Front Psychiatry Date: 2017-08-31 Impact factor: 4.157
Authors: Jakob Johne; Sebastian von Peter; Julian Schwarz; Jürgen Timm; Martin Heinze; Yuriy Ignatyev Journal: BMC Psychiatry Date: 2018-09-03 Impact factor: 3.630
Authors: Bettina Soltmann; Anne Neumann; Stefanie March; Ines Weinhold; Dennis Häckl; Roman Kliemt; Fabian Baum; Marcel Romanos; Julian Schwarz; Sebastian von Peter; Yuriy Ignatyev; Katrin Arnold; Enno Swart; Martin Heinze; Jochen Schmitt; Andrea Pfennig Journal: Front Psychiatry Date: 2021-06-01 Impact factor: 4.157
Authors: Anne Neumann; Enno Swart; Dennis Häckl; Roman Kliemt; Stefanie March; Denise Küster; Katrin Arnold; Thomas Petzold; Fabian Baum; Martin Seifert; Jessika Weiß; Andrea Pfennig; Jochen Schmitt Journal: BMC Psychiatry Date: 2018-05-18 Impact factor: 3.630